Premium
Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024)
Author(s) -
Racette Brad A.,
Stambuk Mikula,
Perlmutter Joel S.
Publication year - 2002
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.10209
Subject(s) - cervical dystonia , blepharospasm , botulinum toxin , toxin , medicine , dystonia , anesthesia , microbiology and biotechnology , biology , psychiatry
We report on a patient with cranio–cervical dystonia injected with the new, lower protein formulation of botulinum toxin A who developed secondary resistance to this toxin. Subsequent injections with botulinum toxin B provided substantial reduction of blepharospasm. This is the first reported case of secondary resistance to the new preparation of botulinum toxin A. © 2002 Movement Disorder Society
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom